Viewing data from:

Not in the current Orange Book — This application is not listed in FDA's current Orange Book data files (no listed patents or exclusivities). Product and approval data shown are from FDA's Drugs@FDA database.

NAFCILLIN SODIUM

ANDANot in Orange Book

NAFCILLIN SODIUM | A203830 | STERISCIENCE

API Supply Chain3 active DMFs4 inactive

2 active API suppliers hold Drug Master Files for this ingredient. Limited supplier base — potential supply chain risk.

ACS DOBFAR SPANAFCILLIN SODIUM FOR INJECTION (BULK)

DMF 136951998

APITORIA PHARMA PRIVATE LTDNAFCILLIN SODIUM (NON-STERILE DRUG SUBSTANCE INTERMEDIATE)

DMF 224732009

ACS DOBFAR SPANAFCILLIN SODIUM FOR INJECTION (STERILE BULK)

DMF 273132013

FERMENTA PRODUCTS INCInactiveNAFCILLIN SODIUM

DMF 133871998

SMITHKLINE BEECHAM PHARMACEUTICALSInactiveNAFCILLIN SODIUM

DMF 135541998

LATINA PHARMA SPAInactiveNAFCILLIN SODIUM STERILE

DMF 136531998

ACS DOBFAR SPAInactiveNAFCILLIN SODIUM

DMF 136971998

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Products (1)

#001 — EQ 10GM BASE/VIAL

▴

INJECTABLE;INJECTION | Approved: Sep. 25, 2026

No patent or exclusivity listings for this strength.